Semler Scientific, Inc. (SMLR)
NASDAQ: SMLR · Real-Time Price · USD
18.67
-1.66 (-8.17%)
At close: Dec 5, 2025, 4:00 PM EST
18.67
0.00 (0.00%)
After-hours: Dec 5, 2025, 4:06 PM EST
Semler Scientific Revenue
Semler Scientific had revenue of $7.49M in the quarter ending September 30, 2025, a decrease of -44.56%. This brings the company's revenue in the last twelve months to $36.96M, down -37.30% year-over-year. In the year 2024, Semler Scientific had annual revenue of $56.29M, down -17.44%.
Revenue (ttm)
$36.96M
Revenue Growth
-37.30%
P/S Ratio
6.09
Revenue / Employee
$467,797
Employees
79
Market Cap
282.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.29M | -11.89M | -17.44% |
| Dec 31, 2023 | 68.18M | 11.50M | 20.28% |
| Dec 31, 2022 | 56.69M | 3.66M | 6.90% |
| Dec 31, 2021 | 53.03M | 14.42M | 37.36% |
| Dec 31, 2020 | 38.60M | 5.84M | 17.81% |
| Dec 31, 2019 | 32.77M | 11.28M | 52.47% |
| Dec 31, 2018 | 21.49M | 9.04M | 72.59% |
| Dec 31, 2017 | 12.45M | 5.02M | 67.50% |
| Dec 31, 2016 | 7.43M | 433.00K | 6.18% |
| Dec 31, 2015 | 7.00M | 3.37M | 92.60% |
| Dec 31, 2014 | 3.64M | 1.36M | 59.85% |
| Dec 31, 2013 | 2.27M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SMLR News
- 5 weeks ago - Semler Scientific® to Release Third Quarter 2025 Financial Results - PRNewsWire
- 6 weeks ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific - PRNewsWire
- 7 weeks ago - SEMLER DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Semler Scientific Investors to Contact the Firm Before the October 28th Deadline - GlobeNewsWire
- 7 weeks ago - SMLR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific - GlobeNewsWire
- 2 months ago - Shareholders who lost money in shares of Semler Scientific (NASDAQ: SMLR) Should Contact Wolf Haldenstein Immediately - GlobeNewsWire
- 2 months ago - SEMLER SCIENTIFIC INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLR - Business Wire
- 2 months ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific - GlobeNewsWire
- 3 months ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Semler Scientific, Inc. (SMLR) - GlobeNewsWire